Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Mrdovic

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Journal of Personalized Medicine|June 27, 2024
Long-Term Prognostic Impact of Stress Hyperglycemia in Non-Diabetic Patients Treated with Successful Primary Percutaneous Coronary InterventionLidija Savic, Igor Mrdovic, Milika Asanin, et al.
The Journal of Invasive Cardiology|July 7, 2010
Prognostic significance of the occurrence of acute heart failure after successful primary percutaneous coronary interventionLidija Savic, Igor Mrdovic, Jovan Perunicic, et al.
Journal of Interventional Cardiology|November 23, 2011
Impact of the combined left ventricular systolic and renal dysfunction on one-year outcomes after primary percutaneous coronary interventionLidija Savic, Igor Mrdovic, Jovan Perunicic, et al.
Journal of Personalized Medicine|March 28, 2024
Long-Term Prognosis after ST-Elevation Myocardial Infarction in Patients with Premature Coronary Artery DiseaseLidija Savic, Igor Mrdovic, Milika Asanin, et al.
Peptides|March 17, 2012
B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary interventionMilika Asanin, Sanja Stankovic, Igor Mrdovic, et al.
Cardiovascular Drugs and Therapy|February 5, 2016
Clinical Significance of Laboratory-determined Aspirin Poor Responsiveness After Primary Percutaneous Coronary InterventionIgor Mrdovic, Mirko Čolić, Lidija Savic, et al.
European Journal of Heart Failure|June 1, 2005
Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarctionMilika Asanin, Jovan Perunicic, Igor Mrdovic, et al.
European Heart Journal. Acute Cardiovascular Care|February 25, 2014
Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI RegisterIgor Mrdovic, Lidija Savic, Ratko Lasica, et al.
International Heart Journal|September 9, 2006
Temporal variations at the onset of spontaneous acute aortic dissectionRatko M Lasica, Jovan Perunicic, Igor Mrdovic, et al.
Journal of Cardiovascular Development and Disease|July 25, 2025
Long-Term Prognosis in Patients with ST-Elevation Myocardial Infarction Complicated by Heart Failure with Preserved Left Ventricular Ejection FractionLidija Savic, Damjan Simic, Ratko Lasica, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of Personalized Medicine|June 27, 2024
Long-Term Prognostic Impact of Stress Hyperglycemia in Non-Diabetic Patients Treated with Successful Primary Percutaneous Coronary InterventionLidija Savic, Igor Mrdovic, Milika Asanin, et al.
The Journal of Invasive Cardiology|July 7, 2010
Prognostic significance of the occurrence of acute heart failure after successful primary percutaneous coronary interventionLidija Savic, Igor Mrdovic, Jovan Perunicic, et al.
Journal of Interventional Cardiology|November 23, 2011
Impact of the combined left ventricular systolic and renal dysfunction on one-year outcomes after primary percutaneous coronary interventionLidija Savic, Igor Mrdovic, Jovan Perunicic, et al.
Journal of Personalized Medicine|March 28, 2024
Long-Term Prognosis after ST-Elevation Myocardial Infarction in Patients with Premature Coronary Artery DiseaseLidija Savic, Igor Mrdovic, Milika Asanin, et al.
Peptides|March 17, 2012
B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary interventionMilika Asanin, Sanja Stankovic, Igor Mrdovic, et al.
Cardiovascular Drugs and Therapy|February 5, 2016
Clinical Significance of Laboratory-determined Aspirin Poor Responsiveness After Primary Percutaneous Coronary InterventionIgor Mrdovic, Mirko Čolić, Lidija Savic, et al.
European Journal of Heart Failure|June 1, 2005
Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarctionMilika Asanin, Jovan Perunicic, Igor Mrdovic, et al.
European Heart Journal. Acute Cardiovascular Care|February 25, 2014
Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI RegisterIgor Mrdovic, Lidija Savic, Ratko Lasica, et al.
International Heart Journal|September 9, 2006
Temporal variations at the onset of spontaneous acute aortic dissectionRatko M Lasica, Jovan Perunicic, Igor Mrdovic, et al.
Journal of Cardiovascular Development and Disease|July 25, 2025
Long-Term Prognosis in Patients with ST-Elevation Myocardial Infarction Complicated by Heart Failure with Preserved Left Ventricular Ejection FractionLidija Savic, Damjan Simic, Ratko Lasica, et al.
Pageof 5